Cargando…
Hyperkalemia in heart failure
Hyperkalemia is increasingly prevalent in the heart failure population as more people live with heart failure and comorbid conditions such as diabetes and chronic kidney disease. Furthermore, renin–angiotensin–aldosterone (RAAS) inhibitors are a key component of clinical therapy in these populations...
Autores principales: | Sidhu, Kiran, Sanjanwala, Rohan, Zieroth, Shelley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams and Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015190/ https://www.ncbi.nlm.nih.gov/pubmed/31833959 http://dx.doi.org/10.1097/HCO.0000000000000709 |
Ejemplares similares
-
A palliative approach for heart failure end-of-life care
por: Maciver, Jane, et al.
Publicado: (2018) -
Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020) -
Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017) -
VACCINE ASSOCIATED HEART FAILURE
por: Aziz, David, et al.
Publicado: (2022) -
Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Guimaraes, Leonardo, et al.
Publicado: (2020)